Will March 2012 Mark The End Of Regulatory Limbo For Discovery's Surfaxin?
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA has set a March 6 user fee date for action on Discovery Laboratories' synthetic surfactant, which was filed with the agency in 2004 but is now in its fifth review cycle.